About Archit Organosys Limited
Data last updated: 22 December 2025
Archit Organosys Limited is a public limited company based in Ahmadabad City, Gujarat, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 04 August 1993, the company has been in operation for over 33 years.
Registered with ROC Ahmedabad under CIN L24110GJ1993PLC019941. Listed on BSE: 524640.
Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹20.52 Cr. Formerly known as Shri Chlochem Limited. It is led by directors including Kandarp Krishnakant Amin and Archana Kandarp Amin.
Last AGM: 09 September 2024. Financial statements filed for year ended 31 March 2024. Office: Ahmadabad City, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹128.69 Cr, a growth of 11% compared to the previous year.
The company has a workforce of approximately 36 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Archit Organosys. As per MCA filings, the company has open charges of ₹111.01 Cr and satisfied charges of ₹7.35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website architorg.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address903 9Th Floor Venus Benecia Near Pakwan Restaurant, Bodakdev S. G. Highway, Ahmadabad City, Gujarat, India – 380054
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Archit Organosys Limited
Archit Organosys Limited operates one associated brand: Archit Organosys. These brands represent Archit Organosys Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturer and suppliers of monochloro acetic acids for laboratory use | architorg.com |
Competitors & Alternatives of Archit Organosys Limited
Brands and companies operating in the same space as Archit Organosys Limited include Abcam, Meridian Bioscience, Stem Cell Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Abcam
|
Biological reagents and antibodies are developed for life science research. | Cambridge, United Kingdom, United Kingdom | 1998 |
Meridian Bioscience
|
Molecular diagnostic device and kits | Ohio, United States, United States | 1976 |
Stem Cell Technologies
|
Developer of cell culture media and ancillary reagents for life science research | Vancouver, Canada, Canada | 1993 |
BBI Solutions
|
Kits and reagents are developed for life science research applications. | Crumlin, United Kingdom, United Kingdom | 1986 |
Cayman Chem
|
Bioreagents and assay kits are developed, with preclinical services provided. | Ann Arbor, United States, United States | 1980 |
PL BioScience
|
Cell culture solutions for stem cell expansion are provided. | Aachen, Germany, Germany | 2015 |
Teknova
|
Molecular biology reagents and kits are supplied for research applications. | Hollister, United States, United States | 1996 |
BioChain
|
Provider of products and services for clinical diagnosis, genomics, and proteomics | Hayward, United States, United States | 1994 |
Sangon Biotech
|
Research services, reagents, and kits for biotech applications are provided. | Shanghai, China, China | 2003 |
Business Activity of Archit Organosys Limited
Archit Organosys Limited is engaged in multiple principal business activities such as manufacturing, trade, and professional, scientific and technical, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, retail trading, other professional, scientific and technical activities. The company has 3 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
| G | Trade | G2 | Retail Trading | ********* |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | ********* |
Auditor Details of Archit Organosys Limited
Archit Organosys Limited is audited by M/s. G K Choksi & Co. (ICAI peer reviewed, certificate valid till 2029-01-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M/s. G K Choksi & Co. (ICAI peer reviewed, certificate valid till 2029-01-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Archit Organosys Limited
Archit Organosys Limited is currently managed by 9 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kandarp Krishnakant Amin | Whole-Time Director | 22 Jan 2000 | 26 Years 5 Months | Current |
| Archana Kandarp Amin | Whole-Time Director | 01 Apr 2009 | 17 Years 3 Months | Current |
| Shreeraj Vikram Desai | Director | 13 Feb 2020 | 6 Years 4 Months | Current |
| Nikul Jagdishchandra Patel | Director | 05 Aug 2021 | 4 Years 11 Months | Current |
| Archit Kandarpbhai Amin | Whole-Time Director | 12 May 2017 | 9 Years 1 Months | Current |
| Vatsal Shaileshbhai Vora | Director | 26 Jun 2023 | 3 Years 0 Months | Current |
Financials of Archit Organosys Limited FY 2026 filings available
Archit Organosys Limited reported revenue of ₹140.95 Cr (up 12.22% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹140.95 Cr | ₹125.6 Cr | ₹113.19 Cr | ₹127.78 Cr | ₹136.66 Cr | ₹94.51 Cr | ₹76.69 Cr | ₹84.67 Cr |
| Other Income | ₹2.88 Cr | ₹3.09 Cr | ₹2.51 Cr | ₹1.92 Cr | ₹1.92 Cr | ₹54.32 Lakh | ₹2.29 Cr | ₹3.38 Cr |
| Total Income | ₹143.84 Cr | ₹128.69 Cr | ₹115.7 Cr | ₹129.71 Cr | ₹138.58 Cr | ₹95.05 Cr | ₹78.98 Cr | ₹88.05 Cr |
| Cost of Materials Consumed | ₹34.07 Cr | ₹37.47 Cr | ₹34.47 Cr | ₹39.24 Cr | ₹54.06 Cr | ₹30.63 Cr | ₹27.78 Cr | ₹33.18 Cr |
| Purchases of Stock-in-Trade | ₹62.96 Cr | ₹48.53 Cr | ₹43.94 Cr | ₹37.2 Cr | ₹41.72 Cr | ₹30.89 Cr | ₹24.08 Cr | ₹37.95 Cr |
| Changes in Inventories | ₹1.38 Cr | -₹1.06 Cr | -₹15.95 Lakh | ₹65.02 Lakh | -₹18.45 Lakh | -₹41.13 Lakh | ₹1.85 Cr | -₹36.96 Lakh |
| Employee Benefit Expense | ₹7.37 Cr | ₹7.1 Cr | ₹8.14 Cr | ₹7.37 Cr | ₹6.51 Cr | ₹6.1 Cr | ₹6.17 Cr | ₹5.36 Cr |
| Finance Costs | ₹2.29 Cr | ₹2.58 Cr | ₹2.58 Cr | ₹2.21 Cr | ₹2.44 Cr | ₹3.25 Cr | ₹3.15 Cr | ₹3.59 Cr |
| Depreciation & Amortisation | ₹6.01 Cr | ₹5.94 Cr | ₹5.66 Cr | ₹4.83 Cr | ₹4.69 Cr | ₹3.67 Cr | ₹3.47 Cr | ₹2.79 Cr |
| Other Expenses | ₹18.76 Cr | ₹20.59 Cr | ₹20.05 Cr | ₹24.42 Cr | ₹17.93 Cr | ₹16.25 Cr | ₹13.27 Cr | ₹11.81 Cr |
| Total Expenses | ₹132.84 Cr | ₹121.15 Cr | ₹114.68 Cr | ₹115.92 Cr | ₹127.16 Cr | ₹90.37 Cr | ₹79.77 Cr | ₹94.3 Cr |
| Profit Before Exceptional Items & Tax | ₹10.99 Cr | ₹7.54 Cr | ₹1.01 Cr | ₹13.79 Cr | ₹11.43 Cr | ₹4.68 Cr | -₹79.12 Lakh | -₹6.26 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹3.37 Cr | ₹1.65 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.99 Cr | ₹7.54 Cr | ₹4.39 Cr | ₹15.44 Cr | ₹11.43 Cr | ₹4.68 Cr | -₹79.12 Lakh | -₹6.26 Cr |
| Total Tax Expense | ₹2.96 Cr | ₹2.49 Cr | ₹1.05 Cr | ₹4.01 Cr | ₹3.19 Cr | -₹32.24 Lakh | ₹99,000 | -₹1.54 Cr |
| Net Profit | ₹8.03 Cr | ₹5.05 Cr | ₹3.34 Cr | ₹11.43 Cr | ₹8.23 Cr | ₹5.01 Cr | -₹80.11 Lakh | -₹4.72 Cr |
| Other Comprehensive Income | ₹2.06 Lakh | ₹83,000 | -₹1.92 Lakh | ₹7.3 Lakh | ₹2.38 Lakh | ₹4.91 Lakh | -₹1.35 Lakh | ₹4.22 Lakh |
| Total Comprehensive Income | ₹8.05 Cr | ₹5.06 Cr | ₹3.32 Cr | ₹11.5 Cr | ₹8.26 Cr | ₹5.06 Cr | -₹81.46 Lakh | -₹4.67 Cr |
| EBITDA (computed) | ₹19.3 Cr | ₹16.06 Cr | ₹9.25 Cr | ₹20.83 Cr | ₹18.55 Cr | ₹11.59 Cr | ₹5.84 Cr | ₹12.42 Lakh |
| Basic EPS | ₹3.91 | ₹2.46 | ₹1.63 | ₹5.57 | ₹4.01 | ₹3.33 | ₹-0.53 | ₹-3.14 |
| Diluted EPS | ₹3.91 | ₹2.46 | ₹1.63 | ₹5.57 | ₹4.24 | ₹3.33 | ₹-0.53 | ₹-3.14 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹126.67 Cr | ₹122.92 Cr | ₹108.24 Cr | ₹122.48 Cr | ₹103.55 Cr | ₹87.49 Cr | ₹83.17 Cr | ₹84.11 Cr |
| Non-current Assets | ₹65.75 Cr | ₹61.42 Cr | ₹66.75 Cr | ₹69.36 Cr | ₹60.63 Cr | ₹53.37 Cr | ₹52.9 Cr | ₹53.33 Cr |
| Current Assets | ₹60.92 Cr | ₹61.5 Cr | ₹41.49 Cr | ₹52.95 Cr | ₹42.87 Cr | ₹34.11 Cr | ₹30.27 Cr | ₹30.78 Cr |
| Property, Plant & Equipment | ₹49.85 Cr | ₹53.39 Cr | ₹58.89 Cr | ₹50.43 Cr | ₹45.05 Cr | ₹47.67 Cr | ₹50.4 Cr | ₹46.97 Cr |
| Inventories | ₹2.95 Cr | ₹4.3 Cr | ₹3.44 Cr | ₹3.38 Cr | ₹5.94 Cr | ₹3.54 Cr | ₹3.28 Cr | ₹5.84 Cr |
| Trade Receivables | ₹24.55 Cr | ₹23.05 Cr | ₹22.23 Cr | ₹37.36 Cr | ₹27.35 Cr | ₹25 Cr | ₹19.72 Cr | ₹14.35 Cr |
| Cash & Equivalents | ₹1.37 Cr | ₹6.81 Lakh | ₹3.82 Cr | ₹5.12 Cr | ₹5.35 Cr | ₹3.81 Cr | ₹2.95 Cr | ₹4.9 Cr |
| Equity (Net Worth) | ₹76.23 Cr | ₹69.21 Cr | ₹64.15 Cr | ₹61.85 Cr | ₹51.89 Cr | ₹40.54 Cr | ₹34.11 Cr | ₹34.92 Cr |
| Equity Share Capital | ₹20.52 Cr | ₹20.52 Cr | ₹20.52 Cr | ₹20.52 Cr | ₹20.52 Cr | ₹15.02 Cr | ₹15.02 Cr | ₹15.02 Cr |
| Borrowings (Non-current) | ₹2.81 Cr | ₹4.49 Cr | ₹7.63 Cr | ₹14.2 Cr | ₹12.21 Cr | ₹12.11 Cr | ₹12.4 Cr | ₹17.73 Cr |
| Borrowings (Current) | ₹21.86 Cr | ₹22.46 Cr | ₹18.03 Cr | ₹16.75 Cr | ₹19.91 Cr | ₹9.58 Cr | ₹14.3 Cr | ₹13.66 Cr |
| Total Debt (computed) | ₹24.66 Cr | ₹26.95 Cr | ₹25.66 Cr | ₹30.95 Cr | ₹32.12 Cr | ₹21.7 Cr | ₹26.7 Cr | ₹31.4 Cr |
| Current Liabilities | ₹43.22 Cr | ₹45.7 Cr | ₹34.26 Cr | ₹44.13 Cr | ₹37.6 Cr | ₹34.28 Cr | ₹35.58 Cr | ₹31.26 Cr |
| Total Liabilities | ₹50.44 Cr | ₹53.71 Cr | ₹44.09 Cr | ₹60.62 Cr | ₹51.66 Cr | ₹46.95 Cr | ₹49.06 Cr | ₹49.19 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹2.68 Cr | ₹18.52 Cr | ₹10.2 Cr | ₹16.9 Cr | ₹10.62 Cr |
| Investing Cash Flow | ₹4.39 Cr | -₹20.85 Cr | -₹2.26 Cr | -₹10.98 Cr | -₹11.52 Cr |
| Financing Cash Flow | -₹5.77 Cr | -₹1.43 Cr | -₹9.13 Cr | -₹6.14 Cr | ₹2.43 Cr |
| Capital Expenditure | ₹1.24 Cr | ₹49.76 Lakh | ₹1.61 Cr | ₹13.19 Cr | ₹10.84 Cr |
| Free Cash Flow (computed) | ₹1.44 Cr | ₹18.02 Cr | ₹8.58 Cr | ₹3.71 Cr | -₹21.77 Lakh |
| Dividends Paid | ₹1.03 Cr | ₹5,000 | ₹98.51 Lakh | ₹1.54 Cr | ₹1.03 Cr |
| Net Change in Cash | ₹1.31 Cr | -₹3.75 Cr | -₹1.2 Cr | -₹22.92 Lakh | ₹1.54 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹36.5 Cr | ₹38.4 Cr | ₹32.86 Cr | ₹33.2 Cr | ₹43.18 Cr | ₹25.87 Cr | ₹29.54 Cr | ₹27 Cr |
| Other Income | -₹47.01 Lakh | ₹90.24 Lakh | ₹1.46 Cr | ₹99.53 Lakh | ₹1.06 Cr | ₹93.37 Lakh | ₹62.9 Lakh | ₹46.59 Lakh |
| Total Income | ₹36.03 Cr | ₹39.3 Cr | ₹34.32 Cr | ₹34.19 Cr | ₹44.25 Cr | ₹26.8 Cr | ₹30.17 Cr | ₹27.47 Cr |
| Cost of Materials Consumed | ₹1.94 Cr | ₹14.85 Cr | ₹9.9 Cr | ₹6.83 Cr | ₹11.51 Cr | ₹7.36 Cr | ₹7.88 Cr | ₹10.71 Cr |
| Purchases of Stock-in-Trade | ₹22.43 Cr | ₹13.17 Cr | ₹14.07 Cr | ₹13.29 Cr | ₹20.91 Cr | ₹8.04 Cr | ₹12.5 Cr | ₹7.08 Cr |
| Changes in Inventories | -₹14.03 Lakh | -₹3.08 Lakh | -₹33.01 Lakh | ₹1.88 Cr | -₹1.82 Cr | ₹44.32 Lakh | ₹69.12 Lakh | -₹37.55 Lakh |
| Employee Benefit Expense | ₹1.83 Cr | ₹1.81 Cr | ₹1.94 Cr | ₹1.79 Cr | ₹1.86 Cr | ₹2.16 Cr | ₹2.48 Cr | ₹1.96 Cr |
| Finance Costs | ₹46.2 Lakh | ₹55.56 Lakh | ₹67.4 Lakh | ₹59.66 Lakh | ₹71.15 Lakh | ₹47.18 Lakh | ₹78.07 Lakh | ₹61.58 Lakh |
| Depreciation & Amortisation | ₹1.49 Cr | ₹1.52 Cr | ₹1.52 Cr | ₹1.49 Cr | ₹1.46 Cr | ₹1.49 Cr | ₹1.5 Cr | ₹1.49 Cr |
| Other Expenses | ₹5.55 Cr | ₹3.91 Cr | ₹4.58 Cr | ₹5.27 Cr | ₹6.31 Cr | ₹5.21 Cr | ₹3.14 Cr | ₹4.58 Cr |
| Total Expenses | ₹33.56 Cr | ₹35.79 Cr | ₹32.35 Cr | ₹31.14 Cr | ₹40.94 Cr | ₹25.18 Cr | ₹28.97 Cr | ₹26.06 Cr |
| Profit Before Exceptional Items & Tax | ₹2.47 Cr | ₹3.51 Cr | ₹1.97 Cr | ₹3.05 Cr | ₹3.31 Cr | ₹1.63 Cr | ₹1.2 Cr | ₹1.41 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹2.47 Cr | ₹3.51 Cr | ₹1.97 Cr | ₹3.05 Cr | ₹3.31 Cr | ₹1.63 Cr | ₹1.2 Cr | ₹1.41 Cr |
| Total Tax Expense | ₹44.51 Lakh | ₹1.07 Cr | ₹43.17 Lakh | ₹1.01 Cr | ₹1.29 Cr | ₹61.36 Lakh | ₹18 Lakh | ₹40.54 Lakh |
| Net Profit | ₹2.02 Cr | ₹2.43 Cr | ₹1.54 Cr | ₹2.04 Cr | ₹2.02 Cr | ₹1.01 Cr | ₹1.02 Cr | ₹1.01 Cr |
| Other Comprehensive Income | ₹3.01 Lakh | -₹95,000 | ₹0 | ₹0 | ₹83,000 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹2.05 Cr | ₹2.43 Cr | ₹1.54 Cr | ₹2.04 Cr | ₹2.03 Cr | ₹1.01 Cr | ₹1.02 Cr | ₹1.01 Cr |
| EBITDA (computed) | ₹4.42 Cr | ₹5.58 Cr | ₹4.16 Cr | ₹5.13 Cr | ₹5.48 Cr | ₹3.59 Cr | ₹3.48 Cr | ₹3.51 Cr |
| Basic EPS | ₹0.99 | ₹1.19 | ₹0.75 | ₹0.99 | ₹0.98 | ₹0.49 | ₹0.50 | ₹0.49 |
| Diluted EPS | ₹0.99 | ₹1.19 | ₹0.75 | ₹0.99 | ₹0.98 | ₹0.49 | ₹0.50 | ₹0.49 |
| Metrics | FY 2024 | FY 2023 |
|---|---|---|
| Revenue from Operations | ₹113.19 Cr | ₹127.78 Cr |
| Other Income | ₹2.44 Cr | ₹1.86 Cr |
| Total Income | ₹115.64 Cr | ₹129.64 Cr |
| Cost of Materials Consumed | ₹34.47 Cr | ₹39.24 Cr |
| Purchases of Stock-in-Trade | ₹43.94 Cr | ₹37.2 Cr |
| Changes in Inventories | -₹15.95 Lakh | ₹65.02 Lakh |
| Employee Benefit Expense | ₹8.14 Cr | ₹7.37 Cr |
| Finance Costs | ₹2.58 Cr | ₹2.21 Cr |
| Depreciation & Amortisation | ₹5.66 Cr | ₹4.83 Cr |
| Other Expenses | ₹20.05 Cr | ₹24.43 Cr |
| Total Expenses | ₹114.68 Cr | ₹115.94 Cr |
| Profit Before Exceptional Items & Tax | ₹95.16 Lakh | ₹13.71 Cr |
| Exceptional Items | ₹3.37 Cr | ₹1.65 Cr |
| Profit Before Tax | ₹4.32 Cr | ₹15.36 Cr |
| Total Tax Expense | ₹1.05 Cr | ₹4.01 Cr |
| Net Profit | ₹3.28 Cr | ₹11.35 Cr |
| attributable to Owners | ₹3.28 Cr | - |
| attributable to NCI | ₹0 | - |
| Other Comprehensive Income | -₹1.92 Lakh | ₹7.3 Lakh |
| Total Comprehensive Income | ₹3.26 Cr | ₹11.42 Cr |
| EBITDA (computed) | ₹9.19 Cr | ₹20.75 Cr |
| Basic EPS | ₹1.60 | ₹5.53 |
| Diluted EPS | ₹1.60 | ₹5.53 |
| Metrics | FY 2024 | FY 2023 |
|---|---|---|
| Total Assets | ₹108.24 Cr | ₹122.43 Cr |
| Non-current Assets | ₹66.75 Cr | ₹72.23 Cr |
| Current Assets | ₹41.49 Cr | ₹50.04 Cr |
| Property, Plant & Equipment | ₹58.89 Cr | ₹50.43 Cr |
| Inventories | ₹3.44 Cr | ₹3.38 Cr |
| Trade Receivables | ₹22.23 Cr | ₹37.36 Cr |
| Cash & Equivalents | ₹3.82 Cr | ₹5.13 Cr |
| Equity (Net Worth) | ₹64.15 Cr | ₹61.78 Cr |
| Equity Share Capital | ₹20.52 Cr | ₹20.52 Cr |
| Borrowings (Non-current) | ₹7.63 Cr | ₹14.2 Cr |
| Borrowings (Current) | ₹18.03 Cr | ₹16.75 Cr |
| Total Debt (computed) | ₹25.66 Cr | ₹30.95 Cr |
| Current Liabilities | ₹34.26 Cr | ₹44.16 Cr |
| Total Liabilities | ₹44.09 Cr | ₹60.66 Cr |
| Metrics | FY 2024 | FY 2023 |
|---|---|---|
| Operating Cash Flow | ₹10.1 Cr | ₹19.43 Cr |
| Investing Cash Flow | -₹2.16 Cr | -₹13.61 Cr |
| Financing Cash Flow | -₹9.13 Cr | -₹6.04 Cr |
| Capital Expenditure | ₹1.8 Cr | ₹15.82 Cr |
| Free Cash Flow (computed) | ₹8.3 Cr | ₹3.61 Cr |
| Dividends Paid | ₹98.51 Lakh | ₹1.54 Cr |
| Net Change in Cash | -₹1.19 Cr | -₹22.4 Lakh |
Shareholding Pattern of Archit Organosys Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 65.88%, retail and other public shareholders hold 34.12% of Archit Organosys Limited. The company had 9,446 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 65.88% | 65.86% | 65.39% | 65.39% | 65.30% | 64.84% |
| Public | 34.12% | 34.14% | 34.61% | 34.61% | 34.70% | 35.16% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 65.88% | 65.30% | 63.26% |
| Public | 34.12% | 34.70% | 36.74% |
| Promoter change (YoY, %pts) | +0.58 | +2.04 | - |
Group Structure of Archit Organosys Limited
Archit Organosys Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Archit Organosys Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Archit Life Science Limited | U24290GJ2022PLC135184 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Archit Organosys Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2004 | Others | ₹55.61 Cr | Open |
| 13 Jan 2004 | Others | ₹55.4 Cr | Open |
| 24 Feb 2023 | Others | ₹3.1 Cr | Satisfied |
| 26 Mar 2015 | Icici Bank Limited | ₹25 Lakh | Satisfied |
| 26 Jun 2004 | Union Bank of India | ₹1.6 Cr | Satisfied |
Total charge records: 9 View all charges
Employees and EPFO Compliance at Archit Organosys Limited
Archit Organosys Limited has a workforce of 36 employees as of Apr 06, 2024.
Employee Count & EPFO Data of Archit Organosys Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Archit Organosys Limited
GSTIN & GST Filing Data of Archit Organosys Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Archit Organosys Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Archit Organosys Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Archit Organosys Limited
MSME Payment Delays by Archit Organosys Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Archit Organosys Limited
Subsidiaries & Group Companies of Archit Organosys Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Archit Organosys Limited with ownership details.
MCA Filings & Documents of Archit Organosys Limited
MCA Filings & Documents of Archit Organosys Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Archit Organosys Limited
Recent News on Archit Organosys Limited
Frequently Asked Questions about Archit Organosys Limited
Archit Organosys Limited is an active public limited company in the chemicals and materials sector based in Ahmadabad City, Gujarat, India. It was incorporated on 04 August 1993 (33+ years old) and is registered under CIN L24110GJ1993PLC019941. Listed on BSE: 524640. The company has 36 employees.
Archit Organosys Limited reported revenue of ₹128.69 Cr for FY 2025 (up 11.00% YoY).
The current directors of Archit Organosys Limited are:
- Kandarp Krishnakant Amin
- Archana Kandarp Amin
- Shreeraj Vikram Desai
- Nikul Jagdishchandra Patel
- Archit Kandarpbhai Amin
- Vatsal Shaileshbhai Vora
- Bhavin Gautamkumar Shah
- Anilkumar Ganeshbhai Patel
- Chirag Chouhan
The primary industry of Archit Organosys Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.
Yes. Archit Organosys Limited is listed on BSE with code 524640.
Archit Organosys Limited can be reached at the registered office: 903 9Th Floor Venus Benecia Near Pakwan Restaurant, Bodakdev S. G. Highway, Ahmadabad City, Gujarat, India – 380054, or through the website architorg.com.